These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

679 related items for PubMed ID: 23314316

  • 21. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L, Hejazi SF, Sadeghi MS, Jang SA.
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [Abstract] [Full Text] [Related]

  • 22. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV.
    Circulation; 2004 Nov 02; 110(18):2837-42. PubMed ID: 15492300
    [Abstract] [Full Text] [Related]

  • 23. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR, CAPTAIN Investigators.
    Am Heart J; 2015 Jul 02; 170(1):110-6. PubMed ID: 26093871
    [Abstract] [Full Text] [Related]

  • 24. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
    Dvoršak B, Kanič V, Ekart R, Bevc S, Hojs R.
    Ther Apher Dial; 2013 Aug 02; 17(4):384-90. PubMed ID: 23931876
    [Abstract] [Full Text] [Related]

  • 25. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W, Fu XH, Gu XS, Wang YB, Wang XC, Li W, Jiang YF, Hao GZ, Fan WZ, Xue L.
    Chin Med J (Engl); 2012 Oct 02; 125(19):3368-72. PubMed ID: 23044290
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME, Oraby MA, Ismail HM, Maklady FA.
    J Interv Cardiol; 2012 Aug 02; 25(4):404-10. PubMed ID: 22612071
    [Abstract] [Full Text] [Related]

  • 27. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    Guo W, Liu Y, Chen JY, Chen SQ, Li HL, Duan CY, Liu YH, Tan N.
    Angiology; 2015 Sep 02; 66(8):721-6. PubMed ID: 25616679
    [Abstract] [Full Text] [Related]

  • 28. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
    Hafiz AM, Jan MF, Mori N, Shaikh F, Wallach J, Bajwa T, Allaqaband S.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):929-37. PubMed ID: 21542114
    [Abstract] [Full Text] [Related]

  • 29. Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes.
    Helgason D, Long TE, Helgadottir S, Palsson R, Sigurdsson GH, Gudbjartsson T, Indridason OS, Gudmundsdottir IJ, Sigurdsson MI.
    J Nephrol; 2018 Oct 01; 31(5):721-730. PubMed ID: 30187381
    [Abstract] [Full Text] [Related]

  • 30. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S, Ko B, Adabag S.
    Ann Thorac Surg; 2012 Sep 01; 94(3):772-6. PubMed ID: 22835553
    [Abstract] [Full Text] [Related]

  • 31. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, Hodgson JM.
    J Hypertens; 2007 Jan 01; 25(1):227-34. PubMed ID: 17143195
    [Abstract] [Full Text] [Related]

  • 32. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S, Mosleh W, Abdel-Qadir H, Farkouh ME.
    Am J Med; 2014 Oct 01; 127(10):987-1000. PubMed ID: 24852935
    [Abstract] [Full Text] [Related]

  • 33. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
    Azzalini L, Laricchia A, Regazzoli D, Mitomo S, Hachinohe D, Bellini B, Demir OM, Poletti E, Maccagni D, Colombo A.
    J Invasive Cardiol; 2019 Jun 01; 31(6):176-182. PubMed ID: 30865912
    [Abstract] [Full Text] [Related]

  • 34. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention.
    Ohno Y, Maekawa Y, Miyata H, Inoue S, Ishikawa S, Sueyoshi K, Noma S, Kawamura A, Kohsaka S, Fukuda K.
    J Am Coll Cardiol; 2013 Oct 01; 62(14):1260-1266. PubMed ID: 23770181
    [Abstract] [Full Text] [Related]

  • 35. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    Nawa T, Nishigaki K, Kinomura Y, Tanaka T, Yamada Y, Kawasaki M, Minatoguchi S.
    Int J Cardiol; 2015 Sep 15; 195():228-34. PubMed ID: 26048382
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
    Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H.
    J Interv Cardiol; 2013 Feb 15; 26(1):90-6. PubMed ID: 22994682
    [Abstract] [Full Text] [Related]

  • 37. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
    Hoshi T, Sato A, Kakefuda Y, Harunari T, Watabe H, Ojima E, Hiraya D, Abe D, Nishina H, Takeyasu N, Noguchi Y, Aonuma K.
    Int J Cardiol; 2014 Feb 01; 171(2):243-9. PubMed ID: 24393575
    [Abstract] [Full Text] [Related]

  • 38. Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
    Noppakun K, Jitraknatee J, Suteeka Y, Ruengorn C, Nochaiwong S, Gunaparn S, Phrommintikul A, Wongcharoen W.
    Cardiorenal Med; 2024 Feb 01; 14(1):160-166. PubMed ID: 38350427
    [Abstract] [Full Text] [Related]

  • 39. Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
    Gurm HS, Mavromatis K, Bertolet B, Kereiakes DJ, Amin AP, Shah AP, Hanzel GS, Rao S, Thomas JL, Kumar G.
    Catheter Cardiovasc Interv; 2019 Jun 01; 93(7):1228-1235. PubMed ID: 30393942
    [Abstract] [Full Text] [Related]

  • 40. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ.
    JAMA; 2016 Mar 01; 315(9):877-88. PubMed ID: 26906014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.